Published in
American Society of Hematology, Blood, 25(129), p. 3379-3385, 2017
DOI: 10.1182/blood-2017-02-767285
Links
Tools
Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin
Journal article published in 2017 by
Charlene Mantia 
,
Erik J. Uhlmann,
Maneka Puligandla,
Griffin M. Weber,
Donna Neuberg ,
Jeffrey I. Zwicker
,
Erik J. Uhlmann,
Maneka Puligandla,
Griffin M. Weber,
Donna Neuberg ,
Jeffrey I. Zwicker
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points Therapeutic enoxaparin was associated with a greater than threefold increased risk of major ICH in patients with glioma. The PANWARDS risk score was a sensitive predictor of major ICH in glioma.